Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SORT-COPD II
NCT07871890Phase 2Not yet recruiting
- Sponsor
- SMSbiotech
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of small mobile stem cells in chronic obstructive pulmonary disease (COPD), sponsored by SMSbiotech. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
small mobile stem cells
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07871890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07871890.